MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia.
CBC
COVID-19
ICU
MPR
NLR
mortality
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
10
2021
accepted:
09
11
2021
entrez:
1
12
2021
pubmed:
2
12
2021
medline:
2
12
2021
Statut:
epublish
Résumé
The aims of the current study were to evaluate the importance of MPR and NLR as prognostic markers in ICU-admitted COVID-19 patients and to investigate the impact of COVID-19 on hematological and coagulation parameters in patients from Jazan region of Saudi Arabia. This retrospective study was conducted between October 2020 and January 2021 at King Fahad Central Hospital, Jazan region. Medical files, which included the results of complete blood count (CBC), calculated mean platelet volume to platelet count ratio (MPR) and neutrophils-to-lymphocytes ratio (NLR) parameters, coagulation profile and D-dimer test, of 96 (64 male and 32 female) COVID-19-infected patients admitted to the intensive care unit were reviewed. Associations between the test results and COVID-19 infection outcomes (discharged [DC] or passed away [PA]) were measured. The results of the current study demonstrate overall significant differences in CBC parameters between PA group as compared to DC group (P < 0.05). The PA group had a significantly elevated MPR (10.15±12.16 vs 4.04±1.5; P < 0.01) and NLR (18.29±19.82 vs 7.35±9.68; P < 0.01) as compared to the DC group, suggesting an association between these parameters and mortality. Odds ratios analysis also showed that adjustment for demographic variables and comorbidities did not weaken the observed association. Elevated MPR and NLR are associated with poor prognosis in COVID-19 patients and could be useful as therapy management indicators.
Identifiants
pubmed: 34848978
doi: 10.2147/IDR.S342259
pii: 342259
pmc: PMC8627266
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4859-4864Informations de copyright
© 2021 Mobarki et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Clin Lab. 2021 Jul 1;67(7):
pubmed: 34258979
J Med Virol. 2020 Apr;92(4):455-459
pubmed: 31994738
BMC Infect Dis. 2021 Jan 18;21(1):80
pubmed: 33461497
Immunol Invest. 2021 Jan;50(1):92-100
pubmed: 32482134
J Leukoc Biol. 2020 Jul;108(1):17-41
pubmed: 32534467
Ann Intensive Care. 2014 Jun 27;4:20
pubmed: 25520853
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154
pubmed: 32602883
Curr Pharm Des. 2011;17(1):47-58
pubmed: 21247392
Clin Lab. 2021 Aug 1;67(8):
pubmed: 34383425
Scand J Clin Lab Invest. 2020 Nov;80(7):536-540
pubmed: 32804580
Am J Emerg Med. 2020 Mar;38(3):641-647
pubmed: 31785981
Sci Rep. 2018 Oct 11;8(1):15123
pubmed: 30310107
Int Immunopharmacol. 2020 Jul;84:106504
pubmed: 32304994
Heart. 2018 Jan;104(1):45-50
pubmed: 28663364
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Clin Lab Anal. 2021 Jan;35(1):e23607
pubmed: 33128497
Front Mol Biosci. 2020 Jul 03;7:157
pubmed: 32719810
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Shock. 2020 Nov;54(5):652-658
pubmed: 32554992
J Clin Med Res. 2020 Jul;12(7):448-453
pubmed: 32655740
Lancet. 2020 Mar 21;395(10228):e52
pubmed: 32171074
J Transl Med. 2020 May 20;18(1):206
pubmed: 32434518
Am J Clin Pathol. 2021 Feb 11;155(3):364-375
pubmed: 33269374
Rev Assoc Med Bras (1992). 2020 Aug;66(8):1122-1127
pubmed: 32935808
J Epidemiol Glob Health. 2021 Mar;11(1):98-104
pubmed: 33095982
Epidemiol Infect. 2020 Jul 09;148:e139
pubmed: 32641174
J Infect Public Health. 2021 Aug;14(8):994-1000
pubmed: 34153731
Cell Death Differ. 2021 Nov;28(11):3125-3139
pubmed: 34031543
Immunol Lett. 2020 Sep;225:31-32
pubmed: 32569607
Crit Care. 2020 Nov 16;24(1):647
pubmed: 33198786
Diabetes Metab Syndr Obes. 2021 Jan 29;14:409-415
pubmed: 33542640
J Med Virol. 2021 Apr;93(4):2221-2226
pubmed: 33135801
EBioMedicine. 2020 May;55:102763
pubmed: 32361250
J Infect Public Health. 2020 Dec;13(12):1833-1839
pubmed: 32788073
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Emerg Infect Dis. 2020 Aug;26(8):1839-1841
pubmed: 32384045
PLoS One. 2020 Dec 15;15(12):e0243604
pubmed: 33320874
Saudi Med J. 2021 Apr;42(4):370-376
pubmed: 33795491
Invest Radiol. 2020 May;55(5):257-261
pubmed: 32091414
Platelets. 2017 Jun;28(4):380-386
pubmed: 27682027
PLoS One. 2021 Jun 21;16(6):e0252939
pubmed: 34153056
PLoS One. 2015 Mar 05;10(3):e0119437
pubmed: 25742300